Kaletra (Lopinavir 200 mg / Ritonavir 50 mg) – Patient Information (Australia)

Kaletra is an antiretroviral medicine used to treat HIV (human immunodeficiency virus). It contains two medicines in each tablet: lopinavir 200 mg and ritonavir 50 mg. The combination works together to reduce the level of HIV in the body and help control the infection.

This page is written to be patient-friendly and focuses on how Kaletra works, how it is typically used, practical tips, and important safety information. Individual needs vary—always follow the instructions provided by your treating team.

Basic product information

• Brand name: Kaletra
• Active ingredients (per dose): Lopinavir 200 mg + Ritonavir 50 mg
• Medicinal class: HIV protease inhibitor (lopinavir boosted with ritonavir)
• Form: Commonly available as tablets (availability may vary by supplier)
• Also known as: Lopinavir/ritonavir
• For use in: HIV treatment regimens (often combined with other antiretroviral medicines)

In Australia, the use of HIV medicines is guided by national and specialist clinical recommendations, and supply is subject to pharmaceutical availability and prescribing practices within your healthcare setting.

How Kaletra works (mechanism of action)

HIV replicates inside human cells. A crucial step in viral replication requires an enzyme called the HIV protease. Protease cuts large viral proteins into smaller pieces needed to build new, infectious virus particles.

Lopinavir is a protease inhibitor. It blocks HIV protease, preventing correct processing of viral proteins. As a result, the production of new infectious HIV particles is reduced.

Ritonavir is also a protease inhibitor, but in Kaletra its main additional role is to “boost” lopinavir exposure. Ritonavir slows the breakdown of lopinavir in the liver, increasing lopinavir blood levels so it can work more effectively.

Pharmacokinetics (how the body handles Kaletra)

Pharmacokinetics describes how a medicine is absorbed, distributed, metabolised, and eliminated. For Kaletra, the “boosting” effect is central to its performance.

• Absorption: Lopinavir/ritonavir absorption can be influenced by food intake.
• Metabolism: Both components are metabolised mainly in the liver, with a key role for CYP (cytochrome P450) enzymes.
• Boosting effect: Ritonavir increases lopinavir levels by inhibiting relevant metabolic pathways.
• Elimination: Metabolites are excreted primarily via the liver and bile, then through the GI tract. Small amounts may be eliminated via the kidneys.

Because of metabolism by liver enzymes, Kaletra can have significant medicine interactions. This is especially important for medicines that affect or are affected by CYP enzymes.

Typical use in HIV

Kaletra is used as part of combination therapy for HIV. It is designed to lower HIV viral load and maintain viral suppression. In practice, Kaletra is typically used together with other antiretroviral medicines, selected based on your treatment history, viral resistance patterns, other health conditions, and potential drug interactions.

Indications (when it may be used)

Kaletra may be used in adults and some paediatric patients as directed by specialist clinicians for HIV management, including when protease inhibitors are appropriate in a specific regimen.

• HIV treatment as part of combination therapy
• Regimen tailoring where protease inhibitors are indicated due to resistance or prior therapy

Your clinician will determine whether Kaletra is suitable for you. Your regimen may change over time based on blood tests, including viral load and CD4 count.

How to take Kaletra (timing and dosing principles)

Dosing schedules can vary depending on the exact regimen and your individual circumstances. The information below is a patient-friendly overview of common dosing principles.

Typical dosing schedules

Kaletra is commonly taken either:

• Twice daily (BID) in many adult regimens, or
• Adjusted schedules in some settings depending on clinical guidance and other medicines in the regimen.

Exact dosing and whether it is once daily or twice daily should be confirmed with your treating team and the product label supplied with your specific formulation.

Timing tips

• Try to take it at consistent times each day to maintain steady blood levels.
• If you miss a dose, do not double up unless your clinician or pharmacist advises it. Instead, follow the advice provided with your medicine or by your pharmacist.
• Use a daily routine (e.g., with meals) to help you remember.

Food and swallowing considerations

Follow the instructions provided for your specific formulation (tablet vs other form). Many protease inhibitor regimens require attention to food intake for absorption and tolerability.

Food interactions

Food can affect drug absorption for some antiretrovirals. For Kaletra specifically:

• Take with food where advised by your prescriber and the product instructions. This may improve absorption and reduce variability.
• Do not drastically change meal patterns without discussing with your clinician or pharmacist. If you change your diet (for example, intermittent fasting), ask whether timing adjustments are needed.

If you have nausea or appetite changes, speak with your healthcare team. They can help you plan timing and strategies to support adherence while minimising side effects.

Alcohol and medicine interactions

Alcohol

Alcohol can worsen side effects such as nausea, dizziness, and fatigue. In addition, both HIV itself and some antiretrovirals can affect the liver. To reduce the risk of liver strain and unwanted side effects, it’s generally advisable to limit alcohol and discuss safe levels with your clinician.

Important medicine interactions

Kaletra has the potential for major drug interactions because it can inhibit/affect enzymes and transporters involved in how other medicines are processed.

Tell your pharmacist and treating team about all medicines you use, including:

• Prescription medicines
• Over-the-counter medicines
• Herbal products and supplements
• Medicines for common conditions (sleep, anxiety, pain, reflux, cholesterol, diabetes)

Examples of interaction risk (general information)

Some medicines may be unsafe with Kaletra or may require close monitoring and dose adjustments. Examples include (not exhaustive):

• Rifampicin/rifabutin (some tuberculosis medicines) – may reduce antiretroviral levels
• St John’s wort (hypericum) – may lower lopinavir/ritonavir levels
• Some antiarrhythmics and medications affecting heart rhythm
• Statins and cholesterol medicines – risk of muscle-related side effects with some statins
• Anticonvulsants (seizure medicines) – may change drug levels
• Hormonal contraceptives – interactions can affect hormone levels
• Oral sedatives and sleep medicines – may increase sedation risk

Because interaction patterns depend on the exact drug and dose, always check with a healthcare professional before starting, stopping, or changing any medicine or supplement.

Safety profile (what to expect and when to seek help)

Common side effects

Like all medicines, Kaletra may cause side effects. Many people experience mild or manageable effects during the early period. Commonly reported effects include:

• Nausea
• Diarrhoea
• Vomiting
• Abdominal discomfort
• Headache
• Fatigue
• Rash (in some patients)

Serious risks (seek medical advice promptly)

Contact your clinician urgently or seek medical help immediately if you experience symptoms that may indicate serious complications, such as:

• Signs of liver problems: yellowing of the skin/eyes (jaundice), dark urine, severe fatigue, pain in the upper abdomen
• Severe allergic reaction: swelling of face/lips, difficulty breathing, severe rash
• Pancreatitis symptoms: severe stomach pain (may extend to the back), persistent vomiting
• Changes in heart rhythm symptoms: fainting, severe dizziness, palpitations
• Signs of high blood sugar or diabetes changes (particularly if you have risk factors)

Laboratory monitoring

Your healthcare team may monitor:

• Viral load (to confirm effectiveness)
• CD4 count
• Liver function tests
• Cholesterol and triglycerides (lipids)
• Blood glucose if at risk

Drug resistance and adherence

HIV medicines are most effective when taken consistently. Missing doses or stopping without advice can increase the risk of viral rebound and may contribute to resistance. If you struggle with adherence, ask your healthcare team about strategies to improve it (reminder systems, timing changes, managing side effects).

Practical use tips for better outcomes

• Take with food if your product instructions recommend it, and keep the routine consistent.
• Use a medication organiser (pill box) or pharmacy blister packs to reduce missed doses.
• Plan for interactions: keep a current list of all medicines and show it to every clinician you see.
• Manage GI side effects: stay hydrated and eat small meals if nausea or diarrhoea occurs—discuss persistent symptoms.
• Be cautious with new supplements: herbal remedies are often not tested for interactions and can be unsafe with protease inhibitors.
• Watch for changes in health: notify your clinician if you develop symptoms suggestive of liver, pancreas, or heart rhythm issues.

Dosing information (patient-friendly overview)

Dosing is individual and depends on the specific treatment plan, your age, liver function, other medicines, and how your body responds. Your healthcare professional will confirm your exact dose.

General principles

• Do not change your dose unless advised by your treating clinician.
• Take at the scheduled times to maintain effective drug levels.
• If you vomit shortly after taking a dose, the amount absorbed may be uncertain. Contact your pharmacist for guidance.

Because dosing schedules can differ across formulations and clinical circumstances, avoid relying only on general internet information. Use the directions provided with your medicine and your care team’s plan.

Alternative options (other HIV treatment approaches)

HIV therapy includes multiple classes of antiretroviral medicines. Alternatives to Kaletra may include:

• Other protease inhibitors (boosted or unboosted, depending on the regimen)
• Integrase strand transfer inhibitors (INSTIs) (commonly used in modern regimens)
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
• Nucleoside reverse transcriptase inhibitors (NRTIs) as part of combination therapy

The best alternative depends on viral resistance, prior treatment history, other medicines you take, liver function, pregnancy considerations, and overall tolerability. Discuss options with your specialist.

Market & legal context for Australia (availability, guidance, and regulation)

In Australia, antiretroviral medicines are regulated and dispensed according to national laws and health system processes. HIV treatment is typically managed through specialist services and infectious diseases clinicians, with support from multidisciplinary healthcare teams.

Supply and access can be influenced by:

• Pharmaceutical availability and commercial supply arrangements
• Eligibility and funding pathways within the Australian healthcare system
• Local clinical guideline recommendations and specialist regimen selection

If you require help accessing HIV medicines, your clinic, pharmacist, or relevant support services can often assist with practical availability information.

Recent guidance and clinical approach (high-level overview)

Clinical recommendations for HIV treatment continue to evolve. In many settings, modern regimens often prioritise: high effectiveness, strong safety profiles, and once-daily or simplified dosing where appropriate.

Protease inhibitor–based regimens, including boosted lopinavir/ritonavir like Kaletra, may still be used when:

• Other options are unsuitable due to resistance or prior treatment history
• Clinicians want a specific resistance profile or treatment approach
• Drug interactions or comorbidities make certain alternatives less suitable

Always rely on up-to-date advice from your HIV specialist and local clinical guidelines.

Delivery and availability (how online pharmacy supply works)

Availability may vary between suppliers. When you order online, delivery time depends on stock status, packing times, and your delivery location within Australia.

What to expect

• Stock checks: orders may be confirmed after verifying supply.
• Packaging: medicines are supplied in compliant packaging with instructions.
• Delivery updates: tracking may be available for dispatch.
• Cold-chain: Kaletra tablets do not typically require special cold-chain handling, but follow packaging instructions.

If you need urgent continuation of therapy, contact the pharmacy team so they can advise on realistic dispatch timelines and alternatives if required.

FAQ

1) What is Kaletra used for?

Kaletra is used to treat HIV as part of combination antiretroviral therapy. It helps reduce viral load and supports long-term control of HIV.

2) How does Kaletra lower HIV levels?

Lopinavir blocks HIV protease, preventing HIV proteins from being processed correctly. Ritonavir boosts lopinavir levels by slowing its breakdown.

3) How should I take Kaletra—once or twice daily?

Many regimens use twice-daily dosing, but dosing schedules can vary. Always follow your treatment plan and the directions on the medicine label.

4) Should I take Kaletra with food?

Food can affect absorption. Many instructions recommend taking Kaletra with food. Follow the exact instructions provided with your formulation and your care team’s guidance.

5) Can I drink alcohol while taking Kaletra?

Alcohol may worsen side effects and could increase liver strain risk. It’s best to limit alcohol and discuss safe options with your clinician, especially if you have liver disease or elevated liver enzymes.

6) What medicines should I avoid with Kaletra?

Some medicines have major interaction risks. Avoid starting new medicines (including herbal supplements like St John’s wort) without checking with a pharmacist or your treating team. Always provide a complete list of your medications.

7) What side effects are most common?

Common side effects include nausea, diarrhoea, vomiting, abdominal discomfort, headache, and fatigue. Many are manageable, but persistent or severe symptoms should be assessed promptly.

8) When should I seek urgent medical help?

Seek urgent help for signs of serious allergic reaction, severe abdominal pain (possible pancreatitis), symptoms of liver problems (e.g., jaundice), or symptoms suggesting heart rhythm problems (e.g., fainting, severe dizziness).

9) If I miss a dose, what should I do?

Don’t double up unless advised. Follow the advice provided by your pharmacist or the product instructions. If you’re unsure, ask your pharmacist for guidance.

10) Are there alternatives to Kaletra?

Yes. HIV treatment can use multiple medicine classes. Alternatives depend on your treatment history, resistance profile, and interactions with other medicines. Discuss options with your HIV specialist.

Quick reference table (at-a-glance)

Important: This information is for general education and does not replace advice from a healthcare professional. If you have questions about suitability, interactions, or how to manage side effects, contact a pharmacist or your HIV specialist.